Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Saul Malozowski"'
Autor:
Philip Raskin, Michael R. Lewis, Jean Park, James H. Ware, Ellen M Vickery, Patricia R. Sheehan, Clifford J. Rosen, Anne L. Peters, Vanita R. Aroda, Richard E. Pratley, Rowena J Dolor, Irwin G. Brodsky, Anastassios G. Pittas, Cyrus Desouza, Saul Malozowski, Jason Nelson, Adline Ghazi, Paul J. Fuss, Patrick M. O'Neil, Lawrence S. Phillips, Neda Rasouli, Karen C. Johnson, Emilia Liao, William C. Knowler, Daniel S. Hsia, Ranee Chatterjee, Sangeeta R. Kashyap, Dave Reboussin, Lisa Ceglia, Erin S. LeBlanc, Patricia Sheehan, John P. Foreyt, Rowena J. Dolor, Sun H. Kim, Chhavi Chadha, Lisa M. Neff, David C. Robbins, Myrlene A. Staten, Bess Dawson-Hughes
Publikováno v:
J Clin Endocrinol Metab
Context Observational studies suggest that low vitamin D status may be a risk factor for cancer. Objective In a population with prediabetes and overweight/obesity that is at higher risk of cancer than the general population, we sought to determine if
Autor:
Michael R. Lewis, James M. Hempe, Philip Raskin, Vanita R. Aroda, Karen C. Johnson, Sun H. Kim, Sangeeta R. Kashyap, Jean Park, David C. Robbins, Cyrus Desouza, Neda Rasouli, William C. Knowler, Erin S. LeBlanc, Patricia R. Sheehan, Irwin G. Brodsky, Christine W. Lary, Emilia Liao, Myrlene A. Staten, Cyruse Desouza, Bess Dawson-Hughes, Richard E. Pratley, John P. Foreyt, Rowena J. Dolor, Ranee Chatterjee, Patrick M. O'Neil, Daniel S. Hsia, Lawrence S. Phillips, Clifford J. Rosen, Chhavi Chadha, Lisa M. Neff, Adline Ghazi, Anne L. Peters, Lisa Ceglia, Saul Malozowski, Anastassios G. Pittas
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 105:e130-e138
Objective Fasting plasma glucose (FPG), 2-hour plasma glucose (2hPG) from a 75-g oral glucose tolerance test (OGTT) and glycated hemoglobin (HbA1c) can lead to different results when diagnosing prediabetes and diabetes. The Hemoglobin Glycation Index
Autor:
Saul Malozowski
Publikováno v:
The Journal of clinical endocrinology and metabolism. 107(5)
Autor:
Karen C, Johnson, Anastassios G, Pittas, Karen L, Margolis, Anne L, Peters, Lawrence S, Phillips, Ellen M, Vickery, Jason, Nelson, Patricia R, Sheehan, David, Reboussin, Saul, Malozowski, Ranee, Chatterjee, William C, Knowler
Publikováno v:
European journal of clinical nutrition. 76(8)
Routine use of vitamin D supplements has increased substantially in the United States. However, the safety and tolerability of long-term use of high-dose vitamin D are not known. We assessed the safety and tolerability of high-dose, daily vitamin DIn
Autor:
Marissa Lightbourne, Saul Malozowski
Publikováno v:
JAMA pediatrics. 175(6)
Autor:
Saul Malozowski
Publikováno v:
Horm Res Paediatr
The benefit/risk ratio of GH use presented by Brown and Bauer (1) in their review encompass more than three decades. The information for GH us is solid but there is no data for recommending IGF-I use in CKD. Its main reference (2) is from the founder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc7717d6f910bff45eb1952b4e235387
https://europepmc.org/articles/PMC8687623/
https://europepmc.org/articles/PMC8687623/
Autor:
Patricia R. Sheehan, Anne L. Peters, Ellen M Vickery, Anastassios G. Pittas, Karen C. Johnson, David M. Reboussin, Ranee Chatterjee, Jason Nelson, Lawrence S. Phillips, Saul Malozowski, Karen L. Margolis
Publikováno v:
Curr Dev Nutr
OBJECTIVES: The routine use of vitamin D supplements has increased substantially in the United States. However, the safety and tolerability of long-term use of high-dose vitamin D are unknown. We assessed the safety and tolerability of vitamin D(3) a
Autor:
John J. Kopchick, Merlin G. Butler, Ricard Nergårdh, Pinchas Cohen, Charlotte Höybye, Gudmundur Johannsson, Tiziana Greggi, Kazuo Chihara, Véronique Beauloye, Keegan Johnson, Anthony P. Goldstone, Mireille M Goetghebeur, Robert D. Nicholls, Maria E. Craig, David B. Allen, Renaldo N. Battista, M. Sara Rosenthal, Graziano Grugni, Anita C. S. Hokken-Koelega, Françoise Muscatelli, Beverly M. K. Biller, Michele Tony, Ilkka Sipilä, Suzanne B. Cassidy, Geoffrey R Ambler, Jennifer L. Miller, Jean-Eric Tarride, Cheri Deal, Annick Vogels, Saul Malozowski, Jens Sandahl Christiansen, Sally Radovick, Glenn Berall, Michael J. Waters, Harriette R. Mogul, Maithé Tauber, Stense Farholt, Alex R. Kemper
Publikováno v:
The Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2013, 98 (6), pp.E1072-E1087. ⟨10.1210/jc.2012-3888⟩
Journal of Clinical Endocrinology and Metabolism, 98(6), E1072-E1087. Endocrine Society
Deal, C L, Tony, M, Höybye, C, Allen, D B, Tauber, M, Christiansen, J S & the 2011 GH in PWS Clinical Care Guidelines Workshop Participants 2013, ' Growth Hormone Research Society Workshop Summary : Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome ', Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 6, pp. E1072-87 . https://doi.org/10.1210/jc.2012-3888
Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2013, 98 (6), pp.E1072-E1087. ⟨10.1210/jc.2012-3888⟩
Journal of Clinical Endocrinology and Metabolism, 98(6), E1072-E1087. Endocrine Society
Deal, C L, Tony, M, Höybye, C, Allen, D B, Tauber, M, Christiansen, J S & the 2011 GH in PWS Clinical Care Guidelines Workshop Participants 2013, ' Growth Hormone Research Society Workshop Summary : Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome ', Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 6, pp. E1072-87 . https://doi.org/10.1210/jc.2012-3888
Context: Recombinant human GH (rhGH) therapy in Prader-Willi syndrome (PWS) has been used by the medical community and advocated by parental support groups since its approval in the United States in 2000 and in Europe in 2001. Its use in PWS represen
Publikováno v:
Journal of diabetes and its complications. 31(2)
Aims Determine the prevalence of glucocorticoid use in U.S. adults with diabetes and whether prevalence is associated with reduced skeletal health, as measured by fracture history and bisphosphonate use. Methods Participants were age≥20years from t
Autor:
Adrian M. Schnall, David C. Goff, David J. Brillon, Jeffrey L. Probstfield, Robert P. Byington, Saul Malozowski, John B. Buse, Karen L. Margolis, Walter T. Ambrosius, Robert M. Cohen, Matthew C. Riddle, Elizabeth R. Seaquist
Publikováno v:
Diabetes Care
OBJECTIVE Randomized treatment comparing an intensive glycemic treatment strategy with a standard strategy in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial was ended early because of an unexpected excess of mortality in the int